Cargando…
Perspectives on Probiotics and Bronchopulmonary Dysplasia
Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease of preterm infants, associated with high morbidity and hospitalization expenses. With the revolutionary advances in microbiological analysis technology, increasing evidence indicates that children with BPD are affected by lung microbi...
Autores principales: | Yang, Kun, Dong, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649774/ https://www.ncbi.nlm.nih.gov/pubmed/33194897 http://dx.doi.org/10.3389/fped.2020.570247 |
Ejemplares similares
-
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016) -
Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
por: Sakaria, Rishika P., et al.
Publicado: (2022) -
Editorial: Bronchopulmonary dysplasia: latest advances
por: Perveen, Shahana, et al.
Publicado: (2023) -
An Innovative Model of Bronchopulmonary Dysplasia in Premature Infants
por: Zhang, Xiaoyue, et al.
Publicado: (2020) -
T Lymphocytes, Multi-Omic Interactions and Bronchopulmonary Dysplasia
por: Toldi, Gergely, et al.
Publicado: (2021)